Predictors of Sustainability of Response With Cenobamate: Post-hoc Subset Analysis of a Phase 3, Open-Label, Study

被引：0
|
作者：
Stern, Sean [1 ]
Wechsler, Robert [2 ,3 ]
Kerr, Wesley T. [4 ]
Wade, Clarence T. [1 ]
Vossler, David G. [5 ]
Rosenfeld, William E. [6 ]
机构：
[1] SK Life Sci Inc, Paramus, NJ USA
[2] Consultants Epilepsy & Neurol, Boise, ID USA
[3] Idaho Comprehens Epilepsy Ctr, Boise, ID USA
[4] Univ Michigan, Dept Neurol, Ann Arbor, MI USA
[5] Univ Washington, Sch Med, Seattle, WA USA
[6] Comprehens Epilepsy Care Ctr Children & Adults, St Louis, MO USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000202250
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P14-1.005
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Post-hoc analysis of open-label extension period of study MCI186-19 in amyotrophic lateral sclerosis
    Takei, Koji
    Tsuda, Kikumi
    Takahashi, Fumihiro
    Palumb, Joseph
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2017, 18 : 64 - 70
  • [22] Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post-hoc analysis of a long-term open-label study
    Ishigooka, Jun
    Inada, Ken
    Niidome, Kazunari
    Aoki, Kazuo
    Kojima, Yoshitsugu
    Iwashita, Shuichi
    Yamada, Sakiko
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2021, 36 (04)
  • [23] Effects of Cenobamate on Weight: Post-hoc Analyses of Global Phase 2 and 3 Studies
    Ferrari, Louis
    Rosenfeld, William
    NEUROLOGY, 2023, 100 (17)
  • [24] Predictors for Improvement in Patient-Reported Outcomes: Post-Hoc Analysis of a Phase 3 Randomized, Open-Label Study of Eculizumab and Ravulizumab in Complement Inhibitor-Naive Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
    Schrezenmeier, Hubert
    Kulasekararaj, Austin G.
    Mitchelli, Lindsay
    De Latour, Regis Peffault
    Devos, Timothy
    Okamoto, Shinichiro
    Wells, Richard
    Johnston, Karissa
    Popoff, Evan
    Cheung, Antoinette
    Wang, Jimmy
    Gustovic, Philippe
    Wang, Alice
    Tomazoz, Ioannis
    Patel, Yogesh
    Lee, Jong Wook
    BLOOD, 2021, 138
  • [25] Predictors of improvements in patient-reported endpoints: Post-hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria (PNH)
    Schrezenmeier, H.
    Kulasekararaj, A.
    Mitchell, L.
    de Latour, Peffault R.
    Devos, T.
    Okamoto, S.
    Wells, R.
    Johnston, K.
    Popoff, E.
    Cheung, A.
    Gustovic, P.
    Wang, A.
    Wang, J.
    Tomazos, I.
    Patel, Y.
    Lee, J. W.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 235 - 236
  • [26] Post-hoc analysis evaluating safety of atogepant in ADVANCE & open-label extension participants with cardiovascular risk factors
    Blumenfeld, A. M.
    Pavlovic, J. M.
    Harriott, A.
    Best, P. J.
    Monteith, T.
    Ferreira, R.
    Ma, J.
    Smith, J. H.
    Dabruzzo, B. L.
    Nahas, S. J.
    HEADACHE, 2022, 62 : 119 - 119
  • [27] Post-hoc Analysis Evaluating Safety of Atogepant in ADVANCE & Open-Label Extension Participants with Cardiovascular Risk Factors
    Blumenfeld, A.
    Pavlovic, J.
    Harriott, A.
    Best, P.
    Montheith, T.
    Ferreira, R. De Abreu
    Ma, J.
    Smith, J.
    Dabruzzo, B.
    Nahas, S.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [28] MANAGEMENT OF MENORRHAGIA IN A PHASE 3, POST-HOC, OPEN-LABEL STUDY OF RECOMBINANT VON WILLEBRAND FACTOR (RVWF) IN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE (VWD)
    Windyga, J.
    Castaman, G.
    Ozen, G.
    Ploder, B.
    Berthoz, F. Truong
    HAEMOPHILIA, 2020, 26 : 138 - 138
  • [29] Sustainability of Linaclotide Response in Chronic Idiopathic Constipation Patients: A Post-hoc Pooled Analysis of Two Phase 3 Trials
    Lavins, Bernard J.
    Fox, Susan M.
    Reasner, David
    Tripp, Kenneth
    Shea, Elizabeth P.
    Blakesley, Rick
    Shiff, Steven
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S746 - S747
  • [30] Investigation of the predictors of the response to Iguratimod therapy: A post-hoc analysis of post-marketing surveillance study
    Ishiguro, Naoki
    Shibata, Kai
    Yoshimura, Akiko
    Ikeuchi, Satoshi
    Ishii, Mika
    MODERN RHEUMATOLOGY, 2020, 30 (04) : 626 - 632
12345